NDC 0268-6110

BRAZIL NUT

Brazil Nut

BRAZIL NUT is a Percutaneous Injection, Solution in the Non-standardized Allergenic category. It is labeled and distributed by Alk-abello, Inc.. The primary component is Brazil Nut.

Product ID0268-6110_3df12f87-12d7-4d3f-83c0-209927a6088a
NDC0268-6110
Product TypeNon-standardized Allergenic
Proprietary NameBRAZIL NUT
Generic NameBrazil Nut
Dosage FormInjection, Solution
Route of AdministrationPERCUTANEOUS
Marketing Start Date1965-01-01
Marketing CategoryBLA / BLA
Application NumberBLA103753
Labeler NameALK-Abello, Inc.
Substance NameBRAZIL NUT
Active Ingredient Strength0 g/mL
Pharm ClassesNon-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Nut Proteins [EXT]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0268-6110-06

5 mL in 1 VIAL, MULTI-DOSE (0268-6110-06)
Marketing Start Date1965-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0268-6110-10 [00268611010]

BRAZIL NUT INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA103753
Product TypeNON-STANDARDIZED ALLERGENIC
Marketing Start Date1998-02-23

NDC 0268-6110-06 [00268611006]

BRAZIL NUT INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA103753
Product TypeNON-STANDARDIZED ALLERGENIC
Marketing Start Date1965-01-01

Drug Details

Active Ingredients

IngredientStrength
BRAZIL NUT.1 mg/mL

Pharmacological Class

  • Non-Standardized Food Allergenic Extract [EPC]
  • Increased Histamine Release [PE]
  • Cell-mediated Immunity [PE]
  • Allergens [CS]
  • Dietary Proteins [CS]
  • Nut Proteins [EXT]

NDC Crossover Matching brand name "BRAZIL NUT" or generic name "Brazil Nut"

NDCBrand NameGeneric Name
0268-6110BRAZIL NUTBrazil Nut
22840-5782Brazil NutBertholletia excelsa
36987-1530Brazil NutBrazil Nut
36987-1531Brazil NutBrazil Nut
36987-1532Brazil NutBrazil Nut
36987-1533Brazil NutBrazil Nut

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.